TSE:4502Pharmaceuticals
Does Takeda Still Offer Value After Pipeline Progress and a 43% Five Year Gain?
If you are wondering whether Takeda Pharmaceutical is still a solid buy at today’s price, or if the easy gains are behind it, you are in the right place to unpack what the market is really paying for this business.
The stock is up 12.0% over the last year and 43.0% over five years, even after a recent 2.0% dip over the past week and a 6.1% rise in the last month. This suggests sentiment is quietly shifting rather than exploding.
Recent headlines have focused on Takeda’s late stage pipeline...